Publication Type:

Journal Article

Source:

Indian Journal of Clinical Biochemistry, Volume 27, Number 2, p.110-120 (2012)

URL:

http://www.scopus.com/inward/record.url?eid=2-s2.0-84864427863&partnerID=40&md5=4de68681fea997814e9b61c841a6f007

Keywords:

acid phosphatase prostate isoenzyme, alpha fetoprotein, bladder cancer, body fluid, breast cancer, CA 125 antigen, CA 19-9 antigen, cancer screening, carbohydrate antigen, chorionic gonadotropin beta subunit, colorectal cancer, cyclin E, cytokeratin, DNA topoisomerase (ATP hydrolysing), enzyme linked immunosorbent assay, epidermal growth factor receptor 2, esophagus cancer, estradiol, estrogen receptor, Gene expression profiling, head and neck cancer, human, immunohistochemistry, inhibin, kidney cancer, liver cancer, lung cancer, lymphoma, Melanoma, micrometastasis, mouth cancer, mucin like carcinoma associated antigen, Muellerian inhibiting factor, neuron specific enolase, nonhuman, pancreas cancer, progesterone receptor, prostate cancer, protein S 100, proteomics, radioimmunoassay, Reliability, review, sensitivity and specificity, squamous cell carcinoma antigen, stomach cancer, telomerase reverse transcriptase

Abstract:

Tumor markers are molecules produced in the body in response to cancer. An ideal tumor marker should have high sensitivity and specificity, should be cheap, and should be easily detected in body fluids. Identification of novel markers is important and it is expected that with the advent of newer technologies, more reliable markers will be discovered. This review discusses the currently available tumor markers for different malignancies. © 2012 Association of Clinical Biochemists of India.

Notes:

cited By 7

Cite this Research Publication

K. Vaidyanathan and Dr. Damodaran Vasudevan, “Organ specific tumor markers: What's new?”, Indian Journal of Clinical Biochemistry, vol. 27, pp. 110-120, 2012.

207
PROGRAMS
OFFERED
5
AMRITA
CAMPUSES
15
CONSTITUENT
SCHOOLS
A
GRADE BY
NAAC, MHRD
8th
RANK(INDIA):
NIRF 2018
150+
INTERNATIONAL
PARTNERS